Offering choice in female condoms: The South African experience

Abstract

South Africa (SA) has an integrated male and female condom (FC) programme. Since 2014, the programme has introduced two new FC brands. This study evaluated the early introduction of the availability of new FCs. Twenty-three sites participating in the National SA Female Condom Evaluation were included. Providers and clients completed interviewer-administered questionnaires assessing FC brand availability, length of distribution, how clients are informed about new FCs and reactions to the choice of more than one FC. A total of 55 providers and 51 clients were interviewed. Although all 23 sites reported they had distributed new FCs, only one had all three types available. Almost all providers (96%) thought it was important to increase choice, although some (27%) worried that having different FCs may confuse clients. Almost all clients (96%) felt it was important to increase the choice of FCs, and most women (80%) felt that using one type of FC would make it easy to use another type. Providers called for more brand-specific Information, Education and Communication (IEC) training for themselves and the community. Providers and clients seem to be very positive about the choice of FCs. Providers recommended more support in the form of IEC materials and training to assist in the provision of the expansion of FC brands.

Eliciting Preferences for HIV Prevention Technologies: A Systematic Review

“…The HIV technologies investigated in the included studies were largely focused on PrEP and HIV testing, perhaps reflecting trends in HIV funding and research priorities [110]. Pre-exposure prophylaxis, for example, in its many modalities, such as the oral pill, long-acting injectable, intravaginal device, or topical microbicide gel, accounted for one in three of the studies.…”

Recent Advances and New Challenges in Cisgender Women’s Gynecologic and Obstetric Health in the Context of HIV

“…The need for novel MPTs is becoming widely recognized. 65 While male and female condoms are the only dual protection methods currently available, 66 over 20 MPTs are in development designed to protect women's reproductive health within indications for pregnancy, BV, chlamydia, gonorrhoeae, human papillomavirus, HSV-2, Zika virus, hepatitis C, and other pathogens. 67,68 At the same time innovative service delivery models that successfully integrate HIV and STI services within family planning settings should be brought to scale and evaluated.…”